Statements (72)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:physicist
gptkb:family |
gptkbp:bfsLayer |
9
|
gptkbp:bfsParent |
gptkb:Mycoplasma_capricolum
|
gptkbp:associated_with |
respiratory diseases
genital infections |
gptkbp:characteristics |
small size
fastidious growth requirements pleomorphic shape |
gptkbp:contains |
gptkb:Mycoplasma
Ureaplasma Mycoplasma genus Ureaplasma genus |
gptkbp:first_described_by |
1940s
|
https://www.w3.org/2000/01/rdf-schema#label |
Mycoplasmataceae
|
gptkbp:is_associated_with |
chronic diseases
infertility respiratory diseases autoimmune disorders chronic respiratory conditions genitourinary infections |
gptkbp:is_characterized_by |
lack of cell wall
|
gptkbp:is_essential_for |
gptkb:Company
vaccine development medical microbiology |
gptkbp:is_found_in |
gptkb:garden
gptkb:Person gptkb:mythological_figure gptkb:item |
gptkbp:is_involved_in |
bioremediation
biodegradation |
gptkbp:is_known_for |
interact with host immune system
form biofilms affect livestock lack of cell wall affect crops cause infections evade host defenses exhibit horizontal gene transfer |
gptkbp:is_part_of |
microbial communities
infectious disease research human microbiome plant microbiome class Mollicutes pathogen-host interaction studies animal microbiome |
gptkbp:is_studied_in |
gptkb:hospital
gptkb:item antibiotic resistance antimicrobial resistance evolutionary biology genetic engineering microbiology therapeutic targets pathogenicity vaccine development strategies |
gptkbp:is_used_in |
diagnostic tests
vaccine research research on cell biology studies of host-pathogen interactions |
gptkbp:is_vulnerable_to |
beta-lactam antibiotics
|
gptkbp:notable_members |
Mycoplasma fermentans
Mycoplasma genitalium Mycoplasma hominis Mycoplasma pneumoniae Ureaplasma urealyticum |
gptkbp:sensor |
antibiotics targeting cell wall
|
gptkbp:species |
Mycoplasma fermentans
Mycoplasma genitalium Mycoplasma hominis Mycoplasma pneumoniae Ureaplasma urealyticum |